Events
-
-
-
-
ENDO 2026: Women’s thyroid cancer risk may be linked to reproductive lifespan and hormone therapy
-
ASCO 2026: Lancet Commission predict shortfall of 100 million cancer care workers by 2050
-
ASCO 2026: CAPTURE trial delivers learnings for metastatic breast cancer treatment
-
ASCO 2026: Teclistamab extends survival, deepens remissions in relapsed multiple myeloma
-
ASCO 2026: Lancet Commission predict shortfall of 100 million cancer care workers by 2050
-
-
ASCO 2026: Teclistamab extends survival, deepens remissions in relapsed multiple myeloma
Faecal microbiota transplant pills show promising results for several types of cancer
Faecal microbiota transplants (FMT) can dramatically improve cancer treatment, suggest two ground-breaking studies published in…
ASCO GI 2026: Key gastrointestinal cancer trials shaping practice across CRC, upper GI and hepatobiliary disease
New data presented at the 2026 ASCO Gastrointestinal Cancers Symposium (ASCO GI) highlight continued momentum…
Molecular tumour profiling shows promise in linking patients with advanced or rare cancer to clinical trials in regional Australia
New research from a regional Australian cancer centre has assessed the practical utility of molecular…
Air pollution linked with worse cardiac remodelling and function in breast cancer patients receiving cardiotoxic therapy
- Breast cancer risk markers linked to physical activity in adolescent girls
- PBS listing announced for treatment of unresectable or metastatic, well-differentiated extra-pancreatic or pancreatic neuroendocrine tumours
- NCCN Guidelines acknowledge MammaPrint for guiding anthracycline use in early-stage breast cancer
Unpacking Endometrial Cancer with Professor Linda Mileshkin
Endometrial cancer is the most common gynaecological cancer in Australia and advanced disease and early on set disease are increasing.…
The future of medicine: 50-year forecast offers hope for HIV and cancer patients and predicts climate change to increasingly set agenda
René Rohrbeck, EDHEC Business School; Ahmed Khwaja, Cambridge Judge Business School; Heikki Karjaluoto, University of Jyväskylä; Ignat Kulkov, EDHEC Business…
JOIN THE ONCOLOGY NETWORK
If you would like even more free news articles, access to our exclusive HCP only content including the latest podcasts from The Oncology Podcast and our Industry Partner Podcasts (including links to all papers and show notes), along with all our other resources, head over to The Oncology Network and sign up - FREE forever for HCPs only.